NCT05700045View on ClinicalTrials.gov

TAP Using Dexmedetomidine and Ropivacaine for Cesarean Section Analgesia

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

September 28, 2023

Study Completion Date

September 30, 2023

Conditions
Multimodal AnalgesiaCesarean Section
Interventions
DRUG

Dexmedetomidine

each side dexmedetomidine 0.5ug/kg TAP block

Trial Locations (2)

710032

The Fourth military medical university, Xijing Hospital, Xi'an

Huang Nie, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT05700045 - TAP Using Dexmedetomidine and Ropivacaine for Cesarean Section Analgesia | Biotech Hunter | Biotech Hunter